Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 213 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Integrated Network Pharmacology Analysis and Experimental Validation to Elucidate the Mechanism of Acteoside in Treating Diabetic Kidney Disease
Shu Jiao Zhang, Yi Fei Zhang,Xue Hui Bai,Meng Qi Zhou,Ze Yu Zhang, Shuai Xing Zhang, Zi Jing Cao, Lin Wang, Shao Wei Ding,Hui Juan Zheng,Yu Ning Liu,Guo Yong Yu,
Drug design, development and therapy (2024): 1439-1457
Cited0Views0WOSBibtex
0
0
Thonningianin A Ameliorated Renal Interstitial Fibrosis in Diabetic Nephropathy Mice by Modulating Gut Microbiota Dysbiosis and Repressing Inflammation
Shujiao Zhang, Shuaixing Zhang, Xuehui Bai,Yaoxian Wang, Yuning Liu,Weijing Liu
Frontiers in pharmacology (2024): 1389654-1389654
Cited0Views0WOSBibtex
0
0
Acteoside Delays the Fibrosis Process of Diabetic Nephropathy by Anti-Oxidation and Regulating the Autophagy-Lysosome Pathway
Mengqi Zhou, Shujiao Zhang,Xuehui Bai,Yuzi Cai, Zeyu Zhang,Pingna Zhang,Chengyuan Xue,Huijuan Zheng, Quanmei Sun, Dong Han,Lixia Lou,Yaoxian Wang,
European journal of pharmacologypp.176715-176715, (2024)
Cited0Views0WOSBibtex
0
0
Lipid homeostasis in diabetic kidney disease
Ying Wang,Tongtong Liu, Yun Wu, Lin Wang, Shaowei Ding, Baoluo Hou,Hailing Zhao,Weijing Liu, Ping Li
International journal of biological sciencesno. 10 (2024): 3710-3724
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 204

#Citation: 2714

H-Index: 24

G-Index: 50

Sociability: 6

Diversity: 3

Activity: 77

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn